NOUBAR AFEYAN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NOUBAR AFEYAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NOUBAR AFEYAN. NOUBAR AFEYAN is a Director in AGENUS INC ($AGEN) and a Director in BG Medicine, Inc. ($BGMD) and a Director in Seres Therapeutics, Inc. ($MCRB) and a Director in Moderna, Inc. ($MRNA) and a Director in Evelo Biosciences, Inc. ($EVLO) and a Director in Rubius Therapeutics, Inc. ($RUBY).
Address: 1 SUNSET RIDGE LEXINGTON 02173 MA
Companies in which NOUBAR AFEYAN is an Insider
AGENUS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NOUBAR AFEYAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2007
$AGEN Market Capitalization: $345.02M
$AGEN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BG Medicine, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of NOUBAR AFEYAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 11 2015
$BGMD Market Capitalization: $871563.00
$BGMD Previous Close: $0.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Evelo Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NOUBAR AFEYAN: Director
Holdings: 0 shares
Latest Transaction: Jun 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Moderna, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NOUBAR AFEYAN: Director
Holdings: 12,585,162 shares
Latest Transaction: Mar 31 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rubius Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NOUBAR AFEYAN: Director
Holdings: 0 shares
Latest Transaction: May 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seres Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NOUBAR AFEYAN: Director
Holdings: 4,444,444 shares
Current Value: $42,222,218
Latest Transaction: Jun 20 2019
$MCRB Market Capitalization: $374.90M
$MCRB Previous Close: $9.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of NOUBAR AFEYAN
Sentiment: All, AGEN, BGMD, EVLO, MRNA, RUBY, MCRB
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | RUBY | Rubius Therapeutic ... | AFEYAN NOUBAR | Director | Option Exercise | A | 23.25 | 25,000 | 581,250 | 25,000 | |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.07 | 4,888 | 591,810 | 9,116,657 | 9.1 M to 9.1 M (-0.05 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.44 | 1,000 | 123,440 | 9,121,545 | 9.1 M to 9.1 M (-0.01 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.08 | 31,943 | 3,931,538 | 9,122,545 | 9.2 M to 9.1 M (-0.35 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.71 | 14,379 | 1,750,038 | 9,154,488 | 9.2 M to 9.2 M (-0.16 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 120.76 | 225,732 | 27,259,283 | 9,168,867 | 9.4 M to 9.2 M (-2.40 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 119.81 | 344,542 | 41,278,061 | 9,394,599 | 9.7 M to 9.4 M (-3.54 %) |